129 related articles for article (PubMed ID: 16946018)
1. MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4).
Visintin A; Halmen KA; Khan N; Monks BG; Golenbock DT; Lien E
J Leukoc Biol; 2006 Dec; 80(6):1584-92. PubMed ID: 16946018
[TBL] [Abstract][Full Text] [Related]
2. Mechanism regulating cell surface expression and activation of Toll-like receptor 4.
Saitoh S; Miyake K
Chem Rec; 2006; 6(6):311-9. PubMed ID: 17304555
[TBL] [Abstract][Full Text] [Related]
3. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
Sauter KS; Brcic M; Franchini M; Jungi TW
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
[TBL] [Abstract][Full Text] [Related]
4. Membrane-anchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHO cells.
Shuto T; Kato K; Mori Y; Viriyakosol S; Oba M; Furuta T; Okiyoneda T; Arima H; Suico MA; Kai H
Biochem Biophys Res Commun; 2005 Dec; 338(3):1402-9. PubMed ID: 16263085
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of Cys(88) of Toll-like receptor 4 highlights the critical role of MD-2 in cell surface receptor expression.
Nishitani C; Takahashi M; Mitsuzawa H; Shimizu T; Ariki S; Matsushima N; Kuroki Y
Int Immunol; 2009 Aug; 21(8):925-34. PubMed ID: 19556306
[TBL] [Abstract][Full Text] [Related]
6. Ligand-dependent Toll-like receptor 4 (TLR4)-oligomerization is directly linked with TLR4-signaling.
Saitoh S; Akashi S; Yamada T; Tanimura N; Matsumoto F; Fukase K; Kusumoto S; Kosugi A; Miyake K
J Endotoxin Res; 2004; 10(4):257-60. PubMed ID: 15373971
[TBL] [Abstract][Full Text] [Related]
7. The lipopolysaccharide-recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2.
Ohnishi T; Muroi M; Tanamoto K
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):84-91. PubMed ID: 17614960
[TBL] [Abstract][Full Text] [Related]
8. Soluble MD2 increases TLR4 levels on the epithelial cell surface.
Lauer S; Kunde YA; Apodaca TA; Goldstein B; Hong-Geller E
Cell Immunol; 2009; 255(1-2):8-16. PubMed ID: 18845299
[TBL] [Abstract][Full Text] [Related]
9. MD-2-dependent human Toll-like receptor 4 monoclonal antibodies detect extracellular association of Toll-like receptor 4 with extrinsic soluble MD-2 on the cell surface.
Tsukamoto H; Ihara H; Ito R; Ukai I; Suzuki N; Kimoto M; Tomioka Y; Ikeda Y
Biochem Biophys Res Commun; 2013 Oct; 440(1):31-6. PubMed ID: 24021278
[TBL] [Abstract][Full Text] [Related]
10. The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2.
Nishitani C; Mitsuzawa H; Hyakushima N; Sano H; Matsushima N; Kuroki Y
Biochem Biophys Res Commun; 2005 Mar; 328(2):586-90. PubMed ID: 15694388
[TBL] [Abstract][Full Text] [Related]
11. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells.
Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X
Vet Res; 2008; 39(2):11. PubMed ID: 18096120
[TBL] [Abstract][Full Text] [Related]
12. R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells.
Huber M; Kalis C; Keck S; Jiang Z; Georgel P; Du X; Shamel L; Sovath S; Mudd S; Beutler B; Galanos C; Freudenberg MA
Eur J Immunol; 2006 Mar; 36(3):701-11. PubMed ID: 16506285
[TBL] [Abstract][Full Text] [Related]
13. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization.
Saitoh S; Akashi S; Yamada T; Tanimura N; Kobayashi M; Konno K; Matsumoto F; Fukase K; Kusumoto S; Nagai Y; Kusumoto Y; Kosugi A; Miyake K
Int Immunol; 2004 Jul; 16(7):961-9. PubMed ID: 15184344
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of cell surface Toll-like receptor 4-MD2 expression on dendritic epidermal T cells after the emigration from epidermis during cutaneous inflammation.
Shimura H; Nitahara A; Ito A; Tomiyama K; Ito M; Kawai K
J Dermatol Sci; 2005 Feb; 37(2):101-10. PubMed ID: 15659328
[TBL] [Abstract][Full Text] [Related]
15. MD-2 is required for the full responsiveness of mast cells to LPS but not to PGN.
Ushio H; Nakao A; Supajatura V; Miyake K; Okumura K; Ogawa H
Biochem Biophys Res Commun; 2004 Oct; 323(2):491-8. PubMed ID: 15369778
[TBL] [Abstract][Full Text] [Related]
16. Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: a condition reversed by PKC activation.
Cuschieri J; Billigren J; Maier RV
J Leukoc Biol; 2006 Dec; 80(6):1289-97. PubMed ID: 16959900
[TBL] [Abstract][Full Text] [Related]
17. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model.
Cyr SL; Angers I; Guillot L; Stoica-Popescu I; Lussier M; Qureshi S; Burt DS; Ward BJ
Vaccine; 2009 Jan; 27(3):421-30. PubMed ID: 19013492
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis for lipopolysaccharide mimetic action of Taxol and flavolipin.
Kawasaki K; Gomi K; Kawai Y; Shiozaki M; Nishijima M
J Endotoxin Res; 2003; 9(5):301-7. PubMed ID: 14577846
[TBL] [Abstract][Full Text] [Related]
19. The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation.
Lin FY; Chen YH; Lin YW; Tsai JS; Chen JW; Wang HJ; Chen YL; Li CY; Lin SJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2622-9. PubMed ID: 16990552
[TBL] [Abstract][Full Text] [Related]
20. Ligand-induced differential cross-regulation of Toll-like receptors 2, 4 and 5 in intestinal epithelial cells.
van Aubel RA; Keestra AM; Krooshoop DJ; van Eden W; van Putten JP
Mol Immunol; 2007 Jul; 44(15):3702-14. PubMed ID: 17493681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]